RevoGen Biologics

Revogen Biologics is a biotechnology company dedicated to the development and manufacturing of high-quality biosimilar medicines. Headquartered in Menlo Park, California, with significant research and manufacturing operations in Hyderabad, India, the company focuses on increasing the affordability and accessibility of complex biologic therapies. Their product pipeline includes biosimilar candidates for widely used monoclonal antibodies targeting oncology and autoimmune diseases, such as adalimumab, bevacizumab, and trastuzumab. By employing advanced bioprocessing technologies and rigorous analytical characterization, Revogen Biologics aims to meet global regulatory standards for biosimilarity. The company serves as a bridge between innovative drug development and cost-effective manufacturing to address unmet medical needs in diverse markets.